Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBT Margin (2020 - 2025)

Stemtech (STEK) has disclosed EBT Margin for 6 consecutive years, with 95.34% as the latest value for Q3 2025.

  • Quarterly EBT Margin rose 1821.0% to 95.34% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 79.43% through Sep 2025, up 2329.0% year-over-year, with the annual reading at 74.65% for FY2024, 3572.0% up from the prior year.
  • EBT Margin hit 95.34% in Q3 2025 for Stemtech, down from 42.45% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1660.53% in Q3 2022 to a low of 1956.08% in Q2 2022.
  • Historically, EBT Margin has averaged 114.46% across 5 years, with a median of 75.43% in 2021.
  • Biggest YoY gain for EBT Margin was 224649bps in 2022; the steepest drop was -188065bps in 2022.
  • Year by year, EBT Margin stood at 64.62% in 2021, then skyrocketed by 36bps to 41.32% in 2022, then tumbled by -231bps to 136.88% in 2023, then skyrocketed by 78bps to 30.19% in 2024, then crashed by -216bps to 95.34% in 2025.
  • Business Quant data shows EBT Margin for STEK at 95.34% in Q3 2025, 42.45% in Q2 2025, and 168.05% in Q1 2025.